Endometrial polyp with sex cord-like pattern

International Journal of Gynecological Pathology

Volumn 25, Issue 2, 2006, Pages 170-172

  De Quintal, Maísa Momesso ^a   De Angelo Andrade, Liliana Aparecida Lucci ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endometrial polyp; Sex cord like differentiation; Tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; VIMENTIN;

ADENOMYOSIS; ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; METASTASIS; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEX CORD TUMOR; TUMOR BIOPSY; BREAST TUMOR; CHEMISTRY; ENDOMETRIUM TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POLYP;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL ADHESION MOLECULES; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POLYPS; SEX CORD-GONADAL STROMAL TUMORS; TAMOXIFEN; VIMENTIN;

EID: 33747184563     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000185409.31427.07     Document Type: Article

References (15)

1. Cohen I, Beyth Y, Shapira J, et al. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 1997;44:200-5.
2. Pang LC. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy. South Med J 1998;91:592-4.
3. Eddy G, Mazur MT. Endolymphatic stromal myosis associated with tamoxifen use. Gynecol Oncol 1997;64:262-4.
4. Beer TW, Buchanan R, Buckley CH. Uterine stromal sarcoma following tamoxifen treatment. J Clin Pathol 1995;48:596.
5. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen therapy. Gynecol Oncol 2004;94:256-66.
6. Hachisuga T, Miyakawa T, Tsujioka H, et al. K-ras mutation in tamoxifen-related endometrial polyps. Cancer 2003;98:1890-6.
7. Gilks CB, Clement PB, Hart WR, et al. Uterine adenomyomas excluding atypical polypoid adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with a brief consideration of adenomyomas of other female genital tract sites. Int J Gynecol Pathol 2000;19:195-205.
8. Clement PB, Scully RE. Mullerian adenosarcomas of the uterus with sex cord-like differentiation. A clinicopathologic analysis of eight cases. Am J Clin Pathol 1989;91:664-72.
9. Fornander T, Hellstrom AC, Moberger B. Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer. J Natl Cancer Inst 1993;85:1850-3.
10. Clement PB, Scully RE. Uterine tumors resembling ovarian sex cord tumors: a clinical analysis of fourteen cases. Am J Clin Pathol 1976;66:512-25.
11. Clement PB, Scully RE. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 1992;11:163-73.
12. McCluggage WG. Value of inhibin staining in gynecological pathology. Int J Gynecol Pathol 2001;20:79-85.
13. Baker RJ, Hildebrandt RH, Rouse RV, et al. Inhibin and CD 99 (MIC2) expression in uterine stromal neoplasms with sex cord-like elements. Hum Pathol 1999;30:671-9.
14. Cohen I, Azaria R, Berheim J, et al. Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen. Cancer 2001;92:1151-5.
15. Ismail SM. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994;47:827-33.